Skip to main content
Premium Trial:

Request an Annual Quote

Genaissance Teams with Monsanto, USDA to Map Soybean SNPs

NEW YORK, March 9 (GenomeWeb News) - Genaissance Pharmaceuticals is teaming up with Monsanto and the US Department of Agriculture to map the genome of the soybean plant, in an effort to provide soybean producers with better plant breeding research, Genaissance announced today.

The trio will map and provide plant breeders and geneticists with SNP and single sequence repeat markers in soybeans. The data culled from the effort will be published in USDA's SoyBase, NCBI's dbSNP, and various scientific journals.

According to the agreement, Genaissance will map the soy SNPs, while Monsanto will bankroll the project. The SNP markers to be mapped were provided from the USDA through its main research arm, the Agricultural Research Service.

Genaissance signed up with the USDA for two additional genotyping studies concerning sheep and cattle in October 2004. The company said that the soybean project is part of its extended effort to target the public sector.

The Scan

Lung Cancer Response to Checkpoint Inhibitors Reflected in Circulating Tumor DNA

In non-small cell lung cancer patients, researchers find in JCO Precision Oncology that survival benefits after immune checkpoint blockade coincide with a dip in ctDNA levels.

Study Reviews Family, Provider Responses to Rapid Whole-Genome Sequencing Follow-up

Investigators identified in the European Journal of Human Genetics variable follow-up practices after rapid whole-genome sequencing.

BMI-Related Variants Show Age-Related Stability in UK Biobank Participants

Researchers followed body mass index variant stability with genomic structural equation modeling and genome-wide association studies of 40- to 72-year olds in PLOS Genetics.

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.